Tahereh Foroutan1, Mohsen Nafar2, Elaheh Motamedi3. 1. Department of Animal Biology, Faculty of Biological Sciences, Kharazmi University, Tehran, Iran. 2. Nephrology Department of Erfan Hospital, Tehran, Iran. 3. Department of Nanotechnology, Agricultural Biotechnology Research Institute of Iran (ABRII), Agricultural Research, Education and Extension Organization (AREEO), Karaj, Iran.
Abstract
PURPOSE: Graphene-based nanostructures have shown some degree of stem cell protection against cell death. Acute kidney injury (AKI) is a major cause of mortality in hospitalized patients. Here, graphene oxide (GO) was used to improve the efficacy of bone marrow-derived mesenchymal stem cells (MSCs) in the treatment of AKI induced by cisplatin, a chemotherapy medication used to treat a number of cancers. MATERIALS AND METHODS: Cisplatin-induced AKI was modeled in male rats. Intraperitoneal injection of MSCs mixed with GO, synthesized by graphite powder, H2SO4, and KMnO4 was administered in modeled animals. Biochemical analysis of serum and histological and immunohistochemical (IHC) staining of kidney tissue samples were determined. RESULTS: Administration of GO nanoparticles suspended in MSCs reduced serum levels of creatinine (Cr) and blood urea nitrogen (BUN) in cisplatin-induced AKI in the experimental group compared to the control group. Histopathological evaluation also showed an improvement of morphological alterations of kidney, such as cellular proliferation, apoptosis and necrosis, cyst formation and intratubular debris in the experimental group compared to the control group. Our data revealed that GO injection alone without MSCs accelerated the improvement of the kidney injury induced by cisplatin. CONCLUSION: This study demonstrated that suspended GO could enhance the efficacy of stem cells in the treatment of AKI. GO alone without stem cell accelerates the improvement of cisplatin-induced AKI.
PURPOSE: Graphene-based nanostructures have shown some degree of stem cell protection against cell death. Acute kidney injury (AKI) is a major cause of mortality in hospitalized patients. Here, graphene oxide (GO) was used to improve the efficacy of bone marrow-derived mesenchymal stem cells (MSCs) in the treatment of AKI induced by cisplatin, a chemotherapy medication used to treat a number of cancers. MATERIALS AND METHODS: Cisplatin-induced AKI was modeled in male rats. Intraperitoneal injection of MSCs mixed with GO, synthesized by graphite powder, H2SO4, and KMnO4 was administered in modeled animals. Biochemical analysis of serum and histological and immunohistochemical (IHC) staining of kidney tissue samples were determined. RESULTS: Administration of GO nanoparticles suspended in MSCs reduced serum levels of creatinine (Cr) and blood urea nitrogen (BUN) in cisplatin-induced AKI in the experimental group compared to the control group. Histopathological evaluation also showed an improvement of morphological alterations of kidney, such as cellular proliferation, apoptosis and necrosis, cyst formation and intratubular debris in the experimental group compared to the control group. Our data revealed that GO injection alone without MSCs accelerated the improvement of the kidney injury induced by cisplatin. CONCLUSION: This study demonstrated that suspended GO could enhance the efficacy of stem cells in the treatment of AKI. GO alone without stem cell accelerates the improvement of cisplatin-induced AKI.
Authors: Shruti Kanakia; Jimmy D Toussaint; Sayan Mullick Chowdhury; Tanuf Tembulkar; Stephen Lee; Ya-Ping Jiang; Richard Z Lin; Kenneth R Shroyer; William Moore; Balaji Sitharaman Journal: Biomaterials Date: 2014-05-20 Impact factor: 12.479
Authors: Alena-Svenja Wagner; Kristina Glenske; Anja Henß; Benjamin Kruppke; Sina Rößler; Thomas Hanke; Andreas Moritz; Marcus Rohnke; Monika Kressin; Stefan Arnhold; Reinhard Schnettler; Sabine Wenisch Journal: Biomed Mater Date: 2017-07-04 Impact factor: 3.715
Authors: Suck Won Hong; Jong Ho Lee; Seok Hee Kang; Eun Young Hwang; Yu-Shik Hwang; Mi Hee Lee; Dong-Wook Han; Jong-Chul Park Journal: Biomed Res Int Date: 2014-01-30 Impact factor: 3.411